Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Gold IRA Companies
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Gold IRA Review
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
NBP
Stock Latest News
Ratings
Analyst Reiterates Buy on NovaBridge as Givastomig Advances, Keeps $9 Price Target Unchanged
13h ago
NBP
Premium
Company Announcements
NovaBridge Biosciences Showcases Global Translation Strategy and Givastomig Accelerated Approval Path in August Investor Deck
18h ago
6K
NBP
Premium
Company Announcements
NovaBridge Biosciences Deepens Pipeline Investment as Givastomig and VIS-101 Advance in First-Half 2026
18h ago
6K
NBP
Premium
Company Announcements
NovaBridge Biosciences Sets September 8, 2026 AGM in Shanghai and Highlights 2025 Annual Filing
27d ago
6K
NBP
Premium
Company Announcements
NovaBridge Biosciences Launches 2026 Omnibus Share Incentive Plan
1M ago
6K
NBP
Premium
Company Announcements
NovaBridge Biosciences Names New CEO Amid Broad Board and Executive Shake-Up
2M ago
6K
NBP
Premium
The Fly
NovaBridge CEO Xi-Yong Fu to step down, Srishti Gupta to succeed
2M ago
NBP
Premium
Company Announcements
NovaBridge Biosciences Replaces PwC With Deloitte as Independent Auditor
2M ago
6K
NBP
Premium
Company Announcements
NovaBridge Wins FDA Fast Track for Givastomig in First-Line Gastric Cancer
2M ago
6K
NBP
Premium
Company Announcements
NovaBridge Biosciences Names Veteran Deal-Maker Mark Hagler President and CCO to Steer Late-Stage Oncology and Eye-Drug Push
4M ago
6K
NBP
Premium
Company Announcements
NovaBridge Biosciences Highlights 2025 Results and Advances Late-Stage Oncology and Ophthalmology Programs
5M ago
6K
NBP
Premium
Pre-Earnings
IMAB Upcoming Earnings Report: What to Expect?
5M ago
NBP
Premium
Company Announcements
NovaBridge Wins FDA Backing for Accelerated Approval Pathway for Givastomig in Gastric Cancer
5M ago
6K
NBP
Premium
The Fly
NovaBridge had ‘productive’ FDA meeting on potential gastric cancer treatment
5M ago
NBP
Premium
Company Announcements
NovaBridge and Visara Post Strong VIS-101 Phase 2a Wet AMD Data, Plot Path to Late-Stage Trials
5M ago
6K
NBP
Premium
The Fly
NovaBridge, Visara announce results from VIS-101 Phase 2a Wet AMD study
5M ago
NBP
Premium
Company Announcements
NovaBridge Biosciences Sets March 9 Call to Review Phase 2a VIS-101 Data in Wet AMD
6M ago
6K
NBP
Premium
Company Announcements
NovaBridge Biosciences Unveils February Investor Deck Detailing Global Hub-and-Spoke Biotech Strategy
6M ago
6K
NBP
Premium
The Fly
NovaBridge appoints Cunningham as Vice Chairman of Board of Directors
6M ago
NBP
Premium
Company Announcements
NovaBridge Biosciences Names Emmett Cunningham Vice Chairman to Bolster Biotech Platform
6M ago
6K
NBP
Premium
The Fly
NovaBridge enrolls first patient in givastomig combination study
6M ago
NBP
Premium
Company Announcements
NovaBridge Doses First Patient in Global Phase 2 Gastric Cancer Trial of Givastomig
6M ago
6K
NBP
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
